C
리센스메디컬
394420KOSDAQ54.8 / 100
Reference Date: 2026-09-08
Financial Score20.5 / 40
News Sentiment21.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Declined 10.0% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
License Medical develops innovative medical devices through the FDA De Novo process and specializes in regulatory evaluation for retinal and diagnostic medical devices. The company leverages cryogenic cooling technology and transdermal drug delivery systems to create advanced solutions for ophthalmic conditions such as macular degeneration and diabetic retinopathy.
Number of Employees
55people
Average Salary
54.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
15.31Industry Average 1.200.0Point
12.8x industry avg (risky)
ROE
—Industry Average 8.003.5Point
Debt Ratio
27.41Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 5.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
2.0 / 4
Detailed News Sentiment
1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85
- Positive리센스메디컬 ‘COOLOA 600’, GS홈쇼핑 단독 론칭… ‘완판 행...
GS홈쇼핑 단독 론칭으로 리센스메디컬의 홈뷰티 기기 COOLOA 600의 판매 확대 기대.
Detailed Momentum
52-week position1.0Point
Near 52w low (5%, downtrend)
Current 9,710Won52-week high 33,90052-week low 8,190
1-month return1.0Point
1m -10.01% (falling)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral반기보고서 (2026.06)2026-08-14